Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 511 Records) |
Query Trace: Breast Neoplasms and PIK3CA[original query] |
---|
Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes, chromosomes & cancer 2023 9 . Isabel Grote, Alexandra Poppe, Ulrich Lehmann, Matthias Christgen, Hans Kreipe, Stephan Barte |
Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of PIK3CA-Mutated Breast Cancer. Diagnostics (Basel, Switzerland) 2023 9 13 (18): . Jolanta Smok-Kalwat, Grzegorz Chmielewski, Rafa? Stando, Jacek Sadowski, Pawe? Macek, Artur Kowalik, Ewelina Nowak-Ozimek, Stanis?aw Gó? |
Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. Medicine 2023 9 102 (38): e35267. Jin Hyuk Choi, Jesang Yu, Minjung Jung, Junyong Jekal, Ku Sang Kim, Sung Ui Ju |
Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2023 9 . Sibel Osman, Nesibe Kahraman Çetin, ?brahim Halil Erdo?du, ?brahim Meteo? |
Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations. Frontiers in pharmacology 2023 9 14 1224828. Lijuan Li, Nan Wu, Gaojian Zhuang, Lin Geng, Yu Zeng, Xuan Wang, Shuang Wang, Xianhui Ruan, Xiangqian Zheng, Juntian Liu, Ming G |
Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis. Frontiers in oncology 2023 9 13 1192946. Ta-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Jiun-I Lai, Chih-Yi Hsu, Jiun Jen Lynn, Chi-Cheng Huang, Ling-Ming Tse |
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
Genetic and clinical landscape of ER?+?/PR- breast cancer in China. BMC cancer 2023 12 23 (1): 1189. Danian Dai, Hongmei Wu, Hongkai Zhuang, Rong Chen, Cheng Long, Bo Ch |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Breast cancer research and treatment 2023 12 . Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry, Abde M Abukhde |
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) 2023 12 e1966. R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, I Don |
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA network open 2023 12 6 (12): e2348814. Paola Zagami, Aranzazu Fernandez-Martinez, Naim U Rashid, Katherine A Hoadley, Patricia A Spears, Giuseppe Curigliano, Charles M Perou, Lisa A Car |
Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide study. medRxiv : the preprint server for health sciences 2023 12 . Nijole P Tjader, Abigail J Beer, Johnny Ramroop, Mei-Chee Tai, Jie Ping, Tanish Gandhi, Cara Dauch, Susan L Neuhausen, Elad Ziv, Nereida Sotelo, Shreya Ghanekar, Owen Meadows, Monica Paredes, Jessica Gillespie, Amber Aeilts, Heather Hampel, Wei Zheng, Guochong Jia, Qiang Hu, Lei Wei, Song Liu, Christine B Ambrosone, Julie R Palmer, John D Carpten, Song Yao, Patrick Stevens, Weang-Kee Ho, Jia Wern Pan, Paolo Fadda, Dezheng Huo, Soo-Hwang Teo, Joseph Paul McElroy, Amanda Ewart Tola |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa. ACS omega 2023 11 8 (45): 43318-43331. Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alori |
Mutational and expressional association of the PIK3CA gene with the risk of breast cancer in the Pakistani population. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 1-8. Samina Asghar Abbasi, Rashida Khan, Mehvish Naseer Ahmed, Kashif Hussain, Aayesha Riaz, Qaisar Mansoor, Mazhar Qayyum, Ruqia Mehmood Ba |
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 2023 11 8 (1): 429. Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe |
The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? Annals of translational medicine 2023 11 11 (11): 393. Stanislas Quesada, William Jac |
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer. Acta oncologica (Stockholm, Sweden) 2023 11 1-8. Frances M Reznitsky, Jeanette D Jensen, Ann Knoop, Maj-Britt Jensen, Anne-Vibeke Laenkho |
[Application value of DNA damage repair variants in adjuvant therapy of triple negative breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2023 10 45 (9): 787-795. X Wang, J Yue, Y K Kang, S L Gao, P Yu |
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer. Breast cancer research and treatment 2023 10 . Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Sa |
Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of personalized medicine 2024 4 14 (4): . Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Duygu Gurel, Nurten Akdeniz, Ibrahim Meteog |
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial. EClinicalMedicine 2024 4 71 102520. Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cort |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer. Surgical oncology 2024 4 54 102060. Fara Hassan, Jiang Huai Wang, Donal Peter O'Leary, Mark Corrigan, Henry Paul Redmo |
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane. British journal of cancer 2024 1 . Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bieche, Mario Campone, Anne Patsouris, Monica Arnedos, Paul H Cottu, Jean-Philippe Jacquin, Florence Dalenc, Antoine Pinton, Nicolas Servant, Valéry Attignon, Etienne Rouleau, Alain Morel, François Legrand, Marta Jimenez, Fabrice Andre, Thomas Bachel |
Genomic Alterations of Tumors in HER2-Low Breast Cancers. International journal of molecular sciences 2024 1 25 (2): . Yi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, Chin-Jung Feng, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Pei-Ju Lien, Chun-Yu Liu, Jen-Hwey Chiu, Ling-Ming Tse |
Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current cancer drug targets 2024 1 . Yi Wang, Xianling Du, Hongqiang Xin, Ruimin |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: